SCHEMBL18546248

SCHEMBL18546248

CCOC(=O)Cc1c(C)nc(C)c(-c2cc(F)c3c(c2C)CCCO3)c1-c1cc(F)c2c(c1C)CCCO2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 1/20 0.40
KDM4E B2RXH2 12/20 0.34
CYP2C9 P11712 2/20 0.34
MAPK1 P28482 3/20 0.33
HPGD P15428 7/20 0.32
ALDH1A1 P00352 6/20 0.32
HTT P42858 6/20 0.32
HSD17B10 Q99714 6/20 0.32
L3MBTL1 Q9Y468 4/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
MAPT P10636 3/20 0.32
TDP1 Q9NUW8 3/20 0.32
USP2 O75604 2/20 0.32
MEN1 O00255 2/20 0.32
TP53 P04637 2/20 0.32
ALOX15 P16050 2/20 0.32
KMT2A Q03164 2/20 0.32
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18546536 0.88 NR1I2 (0.42) NR1I2KDM4ESMN1; SMN2KMT2ALMNA
SCHEMBL18546298 0.84 KCNH2 (0.39) NR1I2KDM4EHPGDHSD17B10L3MBTL1
SCHEMBL18944215 0.84 NR1I2 (0.36) NR1I2KDM4EHPGDALDH1A1HSD17B10
SCHEMBL18546300 0.82 NR1I2 (0.41) NR1I2SMN1; SMN2MEN1KMT2ALMNA
SCHEMBL18664243 0.81 NR1I2 (0.36) NR1I2KDM4EHPGDALDH1A1HTT
SCHEMBL18546587 0.81 NR1I2 (0.39) NR1I2KDM4EHPGDALDH1A1SMN1; SMN2
SCHEMBL18944148 0.79 NR1I2 (0.38) NR1I2
SCHEMBL18663914 0.78 NR1I2 (0.37) NR1I2
SCHEMBL18546235 0.78 NR1I2 (0.54) NR1I2CYP3A4
SCHEMBL19263639 0.76 NR1I2 (0.39) NR1I2KDM4EMAPTTSHRPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017029631-A1 PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION VIIV Healthcare UK (No.5) Limited (GB) 2017-02-23 WO disclosed